Sarcopenia Is Associated with Cognitive Impairment in Older Adults: A Systematic Review and Meta-Analysis
- PMID: 31233073
- PMCID: PMC12280443
- DOI: 10.1007/s12603-019-1188-8
Sarcopenia Is Associated with Cognitive Impairment in Older Adults: A Systematic Review and Meta-Analysis
Abstract
Background and objectives: There is little evidence in the literature about the possible relationship between sarcopenia and cognition in older adults. Our objective was to investigate the association between cognitive impairment and sarcopenia in older adults living in the community through a systematic review of published studies.
Research design and methods: We performed a systematic review with meta-analysis through Pubmed, LILACS, Scielo and Web of Science databases between March 1, 2001 and December 18, 2018. We included longitudinal and cross-sectional studies that evaluated sarcopenia and cognition as a primary objective.
Results: Of the 274 studies identified by the systematic review, 10 were included in qualitative analysis (total of 9,703 participants), and 6 were eligible for the meta-analysis (n = 7,045). Mean prevalence of sarcopenia was 10.5%. Cognitive impairment was observed in 269 participants with sarcopenia (40%), compared with 1,616 in non-sarcopenic participants (25.3%). Sarcopenia was significantly associated with cognitive impairment (pooled OR = 2.50, 95% CI = 1.26-4.92; p = 0.008). Heterogeneity across the studies was high and significant (I² = 84%). Discussion and Implications: Our analyzes confirmed that sarcopenic older adults presented a higher prevalence of cognitive impairment. Sarcopenia may represent a risk factor for cognitive decline, but longitudinal studies are needed to explore causality.
Keywords: Cognitive impairment; cognition; dementia; older adults; sarcopenia.
Conflict of interest statement
The authors have no conflict of interest to report.
Figures
References
-
- Cesari M, Rolland Y, Van Kan GA, Bandinelli S, Vellas B, Ferrucci L. Sarcopenia-related parameters and incident disability in older persons: Results from the “Invecchiare in Chianti” study. J Gerontol A Biol Sci Med Sci. 2015;70(4):457–463. 10.1093/gerona/glu181 PubMed PMID: 25320055. - DOI - PMC - PubMed
-
- Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010;39(4):412–423. 10.1093/ageing/afq034 PubMed PMID: 20392703, PMCID 2886201. - DOI - PMC - PubMed
-
- Arango-Lopera VE, Arroyo P, Gutiérrez-Robledo LM, Pérez-Zepeda MU, Cesari M. Mortality as an adverse outcome of sarcopenia. J Nutr Health Aging. 2013;17(3):259–262. 10.1007/s12603-012-0434-0 PubMed PMID: 23459979, PMCID 4764255. - DOI - PMC - PubMed
-
- Landi F, Cruz-Jentoft AJ, Liperoti R, Russo A, Giovannini S, Tosato M, et al. Sarcopenia and mortality risk in frail olderpersons aged 80 years and older: Results from iLSIRENTE study. Age Ageing. 2013;42(2):203–209. 10.1093/ageing/afs194 PubMed PMID: 23321202. - DOI - PubMed
-
- Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R, Mhs The Healthcare Costs of Sarcopenia in the United States. J Am Geriatr Soc. 2004;52(1):80–85. 10.1111/j.1532-5415.2004.52014.x PubMed PMID: 14687319. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical